| |
|
|
|
Tenax Therapeutics  
|
|
1.08 -0.04 (-0.04%) |
11-30 16:00 |
|
Open: |
1.1 |
Pre close: |
1.12 |
Target:
|
1.50
|
|
High: |
1.12 |
Low: |
1.06 |
Resistance:
|
1.28
1.50
|
|
Volume: |
117,515 |
Market Cap: |
14M |
Support:
|
0.99
0.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.09
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.01 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
1.27 |
Stochastic Oscillator |
%K(14,3):
|
56.19  |
|
MA(250): |
1.13 |
%D(3): |
62.10 |
|
Average Volume(K) |
3-Month: |
18156
|
52-Week |
High:
|
2.68 |
|
10-Days: |
22962 |
Low: |
0.25 |
|
RSI |
RSI(14):
|
49.42 |
Change(%): |
-13.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-9.040 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.783 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
